Lyric Acquires Concert to Advance Healthcare Decision Intelligence and Expand the Lyric42 Platform
Acquisition reinforces Lyric's commitment to healthcare decision intelligence across the healthcare ecosystem
Lyric, a trusted leader in healthcare decision intelligence for payment accuracy, today announced its acquisition of Concert, a precision health payment accuracy leader with proprietary technology for translating machine-readable policies into real-time decisions.
The acquisition advances Lyric's mission to build the most innovative and impactful company in healthcare decision intelligence. By combining Concert's proprietary capabilities with Lyric42, Lyric’s Healthcare Decision Intelligence Platform, the company extends its ability to serve clients at a time when advanced diagnostics such as genetic testing and the rapid development of new therapies are reshaping healthcare.
Health plans face urgent demands to manage rising costs and keep pace with rapidly evolving clinical evidence. To meet these demands, plans require solutions that bring policy, data, and decision-making together in the systems they and their providers already use. The combination of Concert's policy intelligence with the Lyric42 platform delivers that solution to Lyric’s clients at a critical moment.
